Livzon Pharma Publishes 2025 Annual Report and AGM Materials Online; Shareholders Asked to Confirm E-Communication Preferences

Bulletin Express04-23

Livzon Pharmaceutical Group Inc. (Livzon Pharma) announced on 23 April 2026 that four key corporate documents—the 2025 Annual Report, a circular dated the same day, the notice and proxy form for the 2025 Annual General Meeting (AGM), and the notice and proxy form for the 2026 First Class Meeting of H-Shareholders—have been released on both the company’s website (www.livzon.com.cn) and the HKEXnews portal (www.hkexnews.hk).

The company is encouraging shareholders to access these materials online and to adopt electronic communication for all future corporate documents. Registered shareholders who have already opted for printed copies will receive the current set by mail. Those who encounter difficulties with electronic access, or who prefer physical documents, may submit the enclosed Request Form to the Hong Kong branch share registrar, Tricor Investor Services Ltd., to obtain hard copies at no cost.

Livzon Pharma highlighted the importance of maintaining a valid email address on file. Shareholders who have not provided, or wish to update, their email address should complete the Request Form and return it to the registrar or send the details to 1513-ecom@vistra.com. Until a functional email address is registered, shareholders will receive notices of publication and actionable corporate communications solely in printed form.

Enquiries regarding the notification can be directed to Tricor’s hotline at (+852) 2980 1333 between 9:00 a.m. and 6:00 p.m., Monday to Friday (excluding public holidays).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1185957247?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-23 22:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1185957247","market":"us","top_or_hot":-1,"title":"Livzon Pharma Publishes 2025 Annual Report and AGM Materials Online; Shareholders Asked to Confirm E-Communication Preferences","media":"Bulletin Express","content":"<p>Livzon Pharmaceutical Group Inc. (Livzon Pharma) announced on 23 April 2026 that four key corporate documents—the 2025 Annual Report, a circular dated the same day, the notice and proxy form for the 2025 Annual General Meeting (AGM), and the notice and proxy form for the 2026 First Class Meeting of H-Shareholders—have been released on both the company’s website (www.livzon.com.cn) and the HKEXnews portal (www.hkexnews.hk).</p>\n<p>The company is encouraging shareholders to access these materials online and to adopt electronic communication for all future corporate documents. Registered shareholders who have already opted for printed copies will receive the current set by mail. Those who encounter difficulties with electronic access, or who prefer physical documents, may submit the enclosed Request Form to the Hong Kong branch share registrar, Tricor Investor Services Ltd., to obtain hard copies at no cost.</p>\n<p>Livzon Pharma highlighted the importance of maintaining a valid email address on file. Shareholders who have not provided, or wish to update, their email address should complete the Request Form and return it to the registrar or send the details to 1513-ecom@vistra.com. Until a functional email address is registered, shareholders will receive notices of publication and actionable corporate communications solely in printed form.</p>\n<p>Enquiries regarding the notification can be directed to Tricor’s hotline at (+852) 2980 1333 between 9:00 a.m. and 6:00 p.m., Monday to Friday (excluding public holidays).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Livzon Pharma Publishes 2025 Annual Report and AGM Materials Online; Shareholders Asked to Confirm E-Communication Preferences</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLivzon Pharma Publishes 2025 Annual Report and AGM Materials Online; Shareholders Asked to Confirm E-Communication Preferences\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-23 22:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Livzon Pharmaceutical Group Inc. (Livzon Pharma) announced on 23 April 2026 that four key corporate documents—the 2025 Annual Report, a circular dated the same day, the notice and proxy form for the 2025 Annual General Meeting (AGM), and the notice and proxy form for the 2026 First Class Meeting of H-Shareholders—have been released on both the company’s website (www.livzon.com.cn) and the HKEXnews portal (www.hkexnews.hk).</p>\n<p>The company is encouraging shareholders to access these materials online and to adopt electronic communication for all future corporate documents. Registered shareholders who have already opted for printed copies will receive the current set by mail. Those who encounter difficulties with electronic access, or who prefer physical documents, may submit the enclosed Request Form to the Hong Kong branch share registrar, Tricor Investor Services Ltd., to obtain hard copies at no cost.</p>\n<p>Livzon Pharma highlighted the importance of maintaining a valid email address on file. Shareholders who have not provided, or wish to update, their email address should complete the Request Form and return it to the registrar or send the details to 1513-ecom@vistra.com. Until a functional email address is registered, shareholders will receive notices of publication and actionable corporate communications solely in printed form.</p>\n<p>Enquiries regarding the notification can be directed to Tricor’s hotline at (+852) 2980 1333 between 9:00 a.m. and 6:00 p.m., Monday to Friday (excluding public holidays).</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01513","symbol_name":"丽珠医药","start_time":0,"source_url":"","article_id":"1185957247","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1185957247","pubTimestamp":1776955412,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Livzon Pharmaceutical Group Inc. (Livzon Pharma) announced on 23 April 2026 that four key corporate documents—the 2025 Annual Report, a circular dated the same day, the notice and proxy form for the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01513":"丽珠医药"},"translate_title":"丽珠医药在线发布2025年年度报告和年度股东大会材料；股东被要求确认电子通讯偏好","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01513":1},"content_text":"Livzon Pharmaceutical Group Inc. (Livzon Pharma) announced on 23 April 2026 that four key corporate documents—the 2025 Annual Report, a circular dated the same day, the notice and proxy form for the 2025 Annual General Meeting (AGM), and the notice and proxy form for the 2026 First Class Meeting of H-Shareholders—have been released on both the company’s website (www.livzon.com.cn) and the HKEXnews portal (www.hkexnews.hk).\nThe company is encouraging shareholders to access these materials online and to adopt electronic communication for all future corporate documents. Registered shareholders who have already opted for printed copies will receive the current set by mail. Those who encounter difficulties with electronic access, or who prefer physical documents, may submit the enclosed Request Form to the Hong Kong branch share registrar, Tricor Investor Services Ltd., to obtain hard copies at no cost.\nLivzon Pharma highlighted the importance of maintaining a valid email address on file. Shareholders who have not provided, or wish to update, their email address should complete the Request Form and return it to the registrar or send the details to 1513-ecom@vistra.com. Until a functional email address is registered, shareholders will receive notices of publication and actionable corporate communications solely in printed form.\nEnquiries regarding the notification can be directed to Tricor’s hotline at (+852) 2980 1333 between 9:00 a.m. and 6:00 p.m., Monday to Friday (excluding public holidays).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.4","shortVersion":"4.42.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1185957247","isCrawlerRequest":true}